Emodin is an anthraquinone derivative that significantly prevents increase in DRP1 expression and, thus, promotes reduced renal cell injury in AKI [154], and magnesium stigmasterate B plays a similar protective role in AKI by targeting DRP1 to renal cells [155]. Here, DNM1L is linked to acute kidney injury.